Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5089608010 | Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 5089732010 | Aztreonam (as aztreonam lysine) 75 mg powder for inhalation solution vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) | Is a | Product containing only aztreonam in pulmonary dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) | Has manufactured dose form | Powder for conventional release inhalation solution | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) | Has unit of presentation | Vial | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) | Has precise active ingredient | Aztreonam lysine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) | Has basis of strength substance | Aztreonam | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aztreonam (as aztreonam lysine) 75 milligram/1 vial powder for conventional release solution for inhalation (clinical drug) | Has presentation strength denominator unit | Vial | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR